Stories
Stories
Offering a breath of life for critically ill patients

A scientist by training, David Green (MBA 1991) is drawing upon his business acumen to lead a science fiction-style breakthrough: the creation of replacement body parts (specifically, the trachea) using a recipient’s stem cells.
Green is CEO of Massachusetts-based Harvard Apparatus Regenerative Technology, which manufactures the synthetic scaffolds and bioreactors used to seed the patient’s own bone marrow cells on the scaffold prior to transplant. The cells quickly grow a new trachea, which, because it is made from the patient’s own cells, is not rejected by the patient’s immune system. Patients suffering from diseases such as inoperable tracheal cancer, or those born without a trachea, have been granted a second chance.
As biotechnology and surgical expertise progress, Green foresees a future without waiting lists for organs such as the esophagus, lung, or heart. “I really think we’re at the beginning of a new era in medicine,” he says.
(Published April 2014)
Support the next generation of leaders Make a gift nowPost a Comment
Related Stories
-
- 15 Dec 2024
- HBS Magazine
Agenda: Amanda E/J Morrison (MBA 2014)
Re: Amanda Johnson (MBA 2014); By: Janelle Nanos -
- 15 Dec 2024
- HBS Magazine
On The Case
Re: Tomislav Mihaljevic (GMP 15); Linda A. Hill (Wallace Brett Donham Professor of Business Administration); By: Jen McFarland Flint -
- 15 Dec 2024
- HBS Magazine
After Ozempic
Re: Kate Mulroney (MBA 1984); Joseph L. Badaracco (John Shad Professor of Business Ethics); By: Jen McFarland Flint; Illustrations by Pete Ryan -
- 21 Nov 2024
- HBS Alumni News
Mother Nurture
Re: Tina Beilinson (MBA 2020); Julia Cole (MBA 2020); Sophia Richter (MBA 2020); Ryan W. Buell (C. D. Spangler Professor of Business Administration); By: Margie Kelley
Stories Featuring David Green
-
- 17 Aug 2011
- HBS Alumni Bulletin
Breath of Life
Re: David Green (MBA 1991)